Day One Biopharmaceuticals, Inc. (DAWN)
8.64
+0.72
(+9.09%)
USD |
NASDAQ |
Dec 08, 16:00
8.74
+0.10
(+1.16%)
After-Hours: 20:00
Day One Biopharmaceuticals EPS Diluted (Quarterly): -0.1908 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mersana Therapeutics, Inc. | -1.511 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Lantheus Holdings, Inc. | 0.4104 |
| iRhythm Technologies, Inc. | -0.162 |
| Perspective Therapeutics, Inc. | -0.3495 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.73M |
| Revenue (Quarterly) | 39.80M |
| Total Expenses (Quarterly) | 59.52M |
| Enterprise Value | 438.43M |
| Gross Profit Margin (Quarterly) | 88.74% |
| Profit Margin (Quarterly) | -49.57% |
| Earnings Yield | -17.19% |
| Normalized Earnings Yield | -17.19 |